Bonness Enterprises Inc’s Bristol-Myers Squibb Co Position
Does Bonness Enterprises Inc own Bristol-Myers Squibb Co (BMY)? Yes — 54.3K shares worth $3M (+1.01% of its 13F portfolio) as of Q2 2026.
Position Value
$3M
Q2 2026
Shares
54.3K
% of Portfolio
+1.01%
Quarters Held
31
currently held
Position History BMY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2026 | 54.3K | $3M | +1.01% |
| Q1 2026 | 54.3K | $3M | +1.21% |
| Q4 2025 | 54.3K | $3M | +1.01% |
| Q3 2025 | 54.3K | $2M | +0.80% |
| Q2 2025 | 54.3K | $3M | +0.82% |
| Q1 2025 | 54.3K | $3M | +1.08% |
| Q4 2024 | 54.3K | $3M | +1.08% |
| Q3 2024 | 54.3K | $3M | +0.93% |
| Q2 2024 | 54.3K | $2M | +0.83% |
| Q1 2024 | 54.3K | $3M | +1.06% |
| Q4 2023 | 54.3K | $3M | +1.17% |
| Q3 2023 | 54.3K | $3M | +1.44% |
| Q2 2023 | 54.3K | $3M | +1.56% |
| Q1 2023 | 54.3K | $4M | +1.68% |
| Q4 2022 | 54.3K | $4M | +1.84% |
| Q3 2022 | 54.3K | $4M | +2.05% |
| Q2 2022 | 54.8K | $4M | +2.11% |
| Q1 2022 | 54.8K | $4M | +1.84% |
| Q4 2021 | 54.8K | $3M | +1.58% |
| Q3 2021 | 53.1K | $3M | +1.60% |
| Q2 2021 | 53.1K | $4M | +1.79% |
| Q1 2021 | 53.1K | $3M | +1.79% |
| Q4 2020 | 53.1K | $3M | +1.84% |
| Q3 2020 | 53.1K | $3M | +1.88% |
| Q2 2020 | 53.1K | $3M | +2.00% |
| Q1 2020 | 53.1K | $3M | +2.14% |
| Q4 2019 | 53.1K | $3M | +2.14% |
| Q3 2019 | 53.1K | $3M | +1.73% |
| Q2 2019 | 53.1K | $2M | +1.50% |
| Q1 2019 | 53.1K | $3M | +1.65% |
| Q4 2018 | 53.1K | $3M | +2.07% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bonness Enterprises Inc’s full portfolio or all institutional holders of BMY.